SCHEMBL23980486

SCHEMBL23980486

Cc1cccc2sc(F)cc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLAU P00749 1/20 0.51
SLC9A1 P19634 4/20 0.45
CYP1A2 P05177 4/20 0.42
CYP2A6 P11509 3/20 0.42
ALDH1A1 P00352 7/20 0.37
GPR3 P46089 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
IDO1 P14902 1/20 0.35
TDO2 P48775 1/20 0.35
ACHE P22303 1/20 0.34
POLB P06746 2/20 0.33
MAPT P10636 2/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33
HCRTR1 O43613 1/20 0.33
LMNA P02545 1/20 0.33
PMM2 O15305 1/20 0.33
MPI P34949 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL806604 0.78 PLAU (0.55) PLAUSLC9A1CYP1A2CYP2A6ALDH1A1
SCHEMBL31425959 0.77 PLAU (0.53) PLAUSLC9A1CYP1A2CYP2A6ALDH1A1
SCHEMBL30617314 0.75 PLAU (0.51) PLAUSLC9A1CYP1A2CYP2A6ALDH1A1
SCHEMBL10689841 0.75 PLAU (0.51) PLAUSLC9A1CYP1A2CYP2A6ALDH1A1
SCHEMBL16361159 0.75 PLAU (0.56) PLAUSLC9A1CYP1A2CYP2A6ALDH1A1
SCHEMBL28524731 0.75 PLAU (0.56) PLAUSLC9A1CYP1A2CYP2A6ALDH1A1
SCHEMBL4805056 0.75 CA2 (0.53) PLAUSLC9A1CYP1A2ALDH1A1GPR3
SCHEMBL23980186 0.75 SLC9A1 (0.49) PLAUSLC9A1CYP1A2ALDH1A1GPR3
SCHEMBL4803355 0.75 CA2 (0.55) SLC9A1ALDH1A1L3MBTL1MEN1KMT2A
Hydrochloric Acid SCHEMBL10586469 0.73 PLAU (0.54) PLAUSLC9A1CYP1A2CYP2A6ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021219072-A1 PREPARATION AND APPLICATION METHOD OF HETEROCYCLIC COMPOUND AS KRAS INHIBITOR 上海科州药物研发有限公司 (CN) 2021-11-04 WO disclosed